The ALL4LIVER Grant funds global community projects (outside the US) that advance education, testing, care linkage, and advocacy to help eliminate viral hepatitis as a public health threat by 2030.
Gilead Sciences' Giving in Africa grant funds nonprofit projects that advance HIV/AIDS and viral hepatitis research, education, and health equity across Africa.
Gilead Sciences’ Giving in Europe & the Middle East grant funds nonprofit projects advancing research, care, and education in HIV, liver, blood, and inflammatory/respiratory diseases across the region.
Corporate Giving - Gilead Sciences supports community organizations with programs that expand disease awareness, prevention and early intervention to advance health equity in underserved communities.
The Giving in Asia grant from Gilead Sciences funds nonprofit-led research and awareness projects in HIV/AIDS, oncology, and viral hepatitis to improve healthcare in Asia.
The Gilead Australia Community Grants Program funds Australian non-profits for innovative projects advancing care, education, and support in HIV, liver disease, metastatic breast cancer, and blood cancer.